Home > News > Uncategorised > SHAREHOLDER UPDATE: FAQS

SHAREHOLDER UPDATE: FAQS

SHAREHOLDER UPDATE: FAQS

Factor Therapeutics has developed a list of Frequently Asked Questions (FAQs) to help answer shareholders’ queries about the results of the Company’s Phase 2 VF00102 study. Please find more information here.